Cells from patients with the genetic disorder ataxiatelangiectasia (A-T) are hypersensitive to ionizing radiation and radiomimetic agents, both of which generate reactive oxygen species capable of causing oxidative damage to DNA and other macromolecules. We describe in A-T cells constitutive activation of pathways that normally respond to genotoxic stress. Basal levels of p53 and p21
Introduction
The human genetic disorder ataxia-telangiectasia (A-T) is characterized by neurodegeneration, immunode®-ciency, premature aging, telangiectases, genomic instability, cancer predisposition and extreme sensitivity to ionizing radiation (see Lavin, 1998 for a recent review). A hallmark of A-T cells is hypersensitivity to agents that cause oxidative damage by generating reactive oxygen species (ROS), including ionizing radiation (IR) and various radiomimetic drugs (Shiloh et al., 1985; Taylor et al., 1989) . This hypersensitivity can be accounted for, at least in part, by failure to repair a signi®cant fraction of DNA double strand breaks (Cornforth and Bedford, 1985; Pandita and Hittelman, 1992; Foray et al., 1997; Dar et al., 1997) .
In addition, these cells are impaired in their ability to activate radiation-induced signal transduction pathways, most notably those that control cell cycle checkpoints (reviewed by Rotman and Shiloh, 1999) . ATM, the gene responsible for A-T, seems to play a central role in sensing oxidative damage to DNA and in subsequent activation of a signaling network, leading to repair of the damage and cellular survival (Rotman and Shiloh, 1997, 1999) .
Constitutive activation of certain cellular functions has been reported occasionally in A-T cells. Singh and Lavin (1991) described the constitutive presence in the nucleus of A-T cells of a DNA-binding protein that is present in the cytoplasm of normal cells, but migrates to the nucleus in response to treatment by agents that generate free radicals (Teale et al., 1993) . Abnormal elevation of interferon-b (IFN-b) and IFN-b-inducible genes (Siddoo-Atwal et al., 1996) in A-T cells was also reported. The amount of p21 associated with cyclin A/ cdk2 and cyclin B/cdc2 was higher in A-T cells than in controls (Beamish et al., 1996) . Basal levels of Gadd45 protein, another gene activated by p53, were also found elevated (Canman et al., 1994) , and the phosphorylated form of cdc2 was more abundant in A-T ®broblasts (Paules et al., 1995) . Hyperphosphorylation of Rb and constitutive activation of E2F-1 in A-T cells were also reported (Khanna et al., 1995; Varghese and Jung, 1998) .
Based on the above mentioned observations, we hypothesized that the chronic activation in ATMde®cient cells of pathways responsive to agents that generate ROS could indicate a tenuous state of oxidative stress in these cells (Rotman and Shiloh, 1997) . This prediction is supported by recent studies showing markers of oxidative stress in organs of Atmde®cient mice (Barlow et al., 1999; Kamsler et al., submitted) and in cell lines derived from A-T patients (Watters et al., 1999) .
Two checkpoint functions that normally respond to genotoxic stress are the activation of p53 and inhibition of cdc2. A combination of post-transcriptional modi®cations of p53 lead to its stabilization and activation following DNA damage (Appella and Anderson, 2000) , resulting in G1/S arrest via induction of its downstream eector, the cdk inhibitor p21. One of the immediate p53 modi®cations in response to ionizing radiation and double strand breaks is phosphorylation of Ser15 of p53 (Siliciano et al., 1997; Shieh et al., 1997; Nakagawa et al., 1999) . Increased phosphorylation of cdc2 on Tyr15 inhibits the activity of the cyclinB/cdc2 complex and prevents entry into mitosis, thereby activating a G2/M checkpoint (reviewed by Shackelford et al., 1999 ).
Here we demonstrate that basal levels of p53, p21, and the phosphorylated forms of cdc2 (on Tyr15) and p53 (on Ser15), are elevated in the majority of A-T cell lines, and that treatment with the antioxidant a-lipoic acid reduces these levels. These results suggest the involvement of ROS in the constitutive activation of such functions, and support the idea that cells lacking ATM are in a continuous state of oxidative stress.
Results
Basal levels of p53 were determined by immunoblotting, in six control and 10 A-T lymphoblastoid cell lines. The amount of p53 was elevated in the majority of the A-T cell lines compared to controls (Figure 1a, b) . Quantitation of these data, determined from several experiments, showed a 2 ± 3-fold increase in p53 in A-T cells (Table 1 ). This increase was not observed under these conditions in AT43RM and AT9RM. The latter is a cell line derived from an A-T variant, whose phenotype is less severe than classical A-T (Gilad et al., 1998) . p53 levels were also increased in two A-T primary ®broblast cell lines compared to controls ( Figure 1c ). In addition, as with p53, basal levels of p21 were increased in A-T cell lines ( Figure 1a ). This was also the case for AT9RM where no signi®cant increase in p53 was detected.
If the elevation of p53 in A-T cells results from increased oxidative damage in these cells, there should be a concomitant increase in Ser15 phosphorylation of p53. The results in Figure 2 indicate that this is indeed the case. Figure 2a again shows that p53 was elevated in A-T cell lines. Higher levels of Ser15 phosphorylation were clearly observed in A-T cells when equal levels of immunoprecipitated p53 were loaded on a gel, whereas no such modi®cation of p53 could be detected in control cells (Figure 2b ). Basal levels of cdc2 in A-T cells were elevated as well, in particular the slow migrating form (Figure 1b ). The identity of this band as the Tyr15 phosphorylated form of cdc2 was con®rmed by using a phospho-speci®c cdc2 (Tyr15) antibody (see below).
Since ATM has been shown to interact with both p53 (Watters et al., 1997; Khanna et al., 1998) and p21 (Kedar et al., unpublished) , it could conceivably have an eect on the stability of these proteins which, in its absence, might accumulate above normal basal levels. Therefore, the stability of both p53 and p21 was determined in the presence of cycloheximide in control and A-T cells. There was rapid degradation of p53 in the ®rst hour followed by a very gradual loss of protein over 4 h. This was also the case for p21, with complete (Figure 3 ). There was no evidence of increased stability of any of these proteins in the A-T cells, since rapid degradation was observed in both C3ABR and AT27R cells.
In order to investigate whether increased levels of ROS could account for the elevated p53 and p21 in A-T cells, we treated these cells with the antioxidant alipoic acid. This versatile antioxidant functions in both the membrane and aqueous phases, quenches a variety of ROS, inhibits reactive oxygen generation, and is able to regenerate other cellular antioxidants (Packer et al., 1995) . The eect of a-lipoic acid on the basal levels of p53 and the Tyr15-phosphorylated form of cdc2 was determined by treating A-T and control lymphoblastoid cells with increasing concentrations of this drug (Figure 4 ). There was a signi®cant reduction in the basal levels of p53 in both normal and control cells, which was dependent on the concentration of the antioxidant. Using a phospho-speci®c antibody against P-Tyr15 of cdc2 we observed higher basal levels of this phosphorylated form in A-T cells, that were reduced with increasing concentrations of a-lipoic acid ( Figure  4b ). The basal levels of the unphosphorylated form of cdc2, which is weakly recognized by this antibody, were similar in control and A-T cells, and did not change with the treatment (Figure 4b ).
Discussion
A-T cells are shown here to have higher basal protein levels of p53 and p21 than controls. These increases are subtle (2 ± 3-fold) but reproducible, and are observed in the great majority of A-T cell lines analysed in this study. In addition, the phosphorylated forms of p53 and cdc2 can be detected in A-T but not control cells. The variant A-T cell line AT9RM displayed increased basal levels of p21, but not of p53 (Figure 1a) . The mutation in this cell line is predicted to lead to the loss of 10 amino acids from the C-terminus of ATM; moreover, unlike classical A-T cell lines which exhibit no detectable levels of ATM protein, AT9RM cells contain reduced levels (17%) of ATM (Gilad et al., 1998) . Accordingly, the phenotype of the patient from whom this cell line was derived is milder, and was de®ned as an A-T variant (Gilad et al., 1998) .
This characteristic chronic activation of stress pathways in A-T cells was not thoroughly studied before, Figure 2 Basal levels of p53 and its Ser15-phosphorylated form in A-T and control cell lines. GM2052 and GM5823 are A-T primary ®broblasts. GM5849 is an SV40-transformed A-T ®broblast cell line. AG1522 and AG6234 are control primary ®broblasts, and GM536 is a control lymphoblastoid cell line. (a) p53 was immunoprecipitated from total cell extracts as described in Materials and methods, and detected by immunoblotting with an anti-p53 antibody (DO1). (b) Equal levels of immunoprecipitated p53 were electrophoresed and immunoblotted with an antip53 antibody (top panel) or an anti Ser15-P phospho-speci®c antibody (bottom panel) Figure 3 Stability of p53 and p21 proteins in A-T (AT27RM) and control (C3ABR) cells. Cells were incubated with cycloheximide (25 mg/ml) for various periods of time up to 4 h. Nuclear extracts were immunoblotted for p53 and p21 as described in Material and methods c Fold increase refers to that over control average although chronic elevations of p21 and cdc2-P-tyr were previously detected (Beamish et al., 1996; Paules et al., 1995) . Higher levels of p53 and p21 were present in testes of Atm-de®cient mice (Barlow et al., 1997) . Constitutively high levels of p21 have also been reported in Atm7/7 MEFs (Xu and Baltimore, 1996; Westphal et al., 1997) . Increased levels of p53 were not detected in these cells, although the eect of ATM-de®ciency on p21 levels is clearly p53-dependent, since the concomitant loss of p53 in MEFs de®cient for Atm completely abolishes p21 levels (Westphal et al., 1997) . A-T ®broblasts and Atm-de®cient MEFs display premature proliferative arrest in culture (Shiloh et al., 1982; Barlow et al., 1996; Elson et al., 1996; Xu and Baltimore, 1996; Westphal et al., 1997) . Replicative failure and concomitant increased levels of p53 and/or p21 have also been observed in cells defective for other genes involved in DNA repair, such as BRCA1 (Hakem et al., 1996) , BRCA2 (Conner et al., 1997; Patel et al., 1998) , and DNA-PK (Kachnic et al., 1999) . Together, these observations suggest that continuous unrepaired DNA damage most likely underlies the chronic activation of cell cycle checkpoints, which in turn lead to proliferative arrest. The constitutive activation of the p53 and cdc2 pathways in untreated ATM-de®cient cells seems to contradict the reduced capacity of these cells to activate such pathways in response to ionizing radiation. However, these signaling cascades are basically intact in these cells and can be activated by other DNA damaging agents. Furthermore, the activation of these responses in A-T cells is suboptimal but not completely abrogated, indicating that ATM is probably responsible for the rapid and ecient induction of such pathways, while other kinases mediate a delayed and reduced response in its absence (reviewed in Rotman and Shiloh, 1999) . ATR was shown to carry out the last phase IR-induction of p53 and Ser15 phosphorylation in A-T cells (Tibbets et al., 1999). Thus, other cellular functions, such as ATR, may be responsible for the subtle but chronic activation of damage-responsive pathways in ATMde®cient cells. The constant trigger might be the continuous presence of double strand breaks in these cells (Kojis et al., 1991; Pandita et al., 1995; Elson et al., 1996) . However, the eect of a-lipoic acid on the basal levels of p53, p21 and cdc2 presented in this study oers an additional explanation ± the involvement of reactive oxygen species (ROS) in the constitutive activation of such pathways.
ROS are generated endogenously as part of normal oxidative metabolism or following exposure to oxidizing agents. At high concentrations these species cause damage to DNA and other macromolecules (Yu, 1994) , whereas at lower concentrations they appear to be important second messengers in signal transduction pathways (Kamata and Hirata, 1999) . ROS have been implicated in aging (Martin et al., 1996) and in many human pathological conditions, including neurodegenerative disorders (Beal, 1995) and chromosomal instability syndromes (Pagano et al., 1998) .
Exogenously applied ROS were shown to induce G1 arrest in proliferating ®broblasts and a concomitant accumulation of p53 and p21 (Gansauge et al., 1997) . Explantation of cells into culture and exposure to higher oxygen levels result in a rise of intracellular ROS. This might explain why the basal p53 levels observed in control cells are also reduced with a-lipoic acid (Figure 4a) . A-T cells might be less ecient in attenuating these rises, resulting in a continuous state of elevated ROS or oxidative stress (Rotman and Shiloh, 1997) , that might account for the activation of p53 and cdc2 pathways shown here, and the constitutive activation of other functions implicated in the stress response (our unpublished results).
A state of continuous oxidative stress in the absence of ATM is supported by the ®ndings of Watters et al. (1999) , who reported increased levels of lipid perox- Figure 4 Eect of a-lipoic acid on p53 and P-Tyr15-cdc2 levels in control and A-T cells. (a) A-T (L4) and control (NL552) lymphoblastoid cell lines were treated with increasing concentrations of a-lipoic acid for 24 h. Untreated cells (U) and cells treated with the same amount of solvent (ethanol) (E) were used as controls. Nuclear extracts were immunoblotted for p53 and cdc2. Actin served as control for equivalent loading. (b) A-T (L6) and control (NL553) lymphoblastoid cell lines were treated with a-lipoic acid as described in (a). Nuclear extracts were immunoblotted with a phospho-speci®c antibody against P-tyr15-cdc2. Equal loading was con®rmed by Ponceau staining of the blots (not shown) idation and decreased catalase activity in A-T ®broblasts. Similarly, Barlow et al. (1999) detected increased oxidative damage of proteins and lipids in target organs of Atm-de®cient mice. In addition, marked elevation in heme oxygenase, which is postulated to play a key role as an antioxidant defense enzyme, were observed in the Atm-de®cient cerebellum. Similarly, changes in the activities of thioredoxin, catalase and manganese superoxide dismutase, were detected in cerebella of Atm-de®cient mice. These changes are indicative of alterations in the redox state of these organs (Kamsler et al., submitted) . A signi®cant reduction in the antioxidant competence of plasma from A-T patients may also be related to these observations (Reichenbach et al., 1999) .
Chronic oxidative stress could account for several features of the pleiotropic phenotype of A-T patients and Atm7/7 mice. These include the preferential loss of particularly sensitive cells such as neurons and thymocytes, premature aging, and the occurrence of telangiectases in the eyes and sun-exposed areas of the skin of A-T patients. Thus, reducing this chronic stress could possibly alleviate some of the features of this disease.
Materials and methods

Cell culture
The characteristics and mutations of A-T ®broblasts and lymphoblastoid lines used in this study have been described previously (Gilad et al., 1996; Watters et al., 1997) . Lymphoblasts were cultured in RPMI-1640 medium, and ®broblasts in Dulbecco's modi®ed Eagle's medium, each supplemented with 10% fetal calf serum.
Immunoblotting
Nuclear extracts were prepared from exponentially growing cells by the procedure described by Dignam et al. (1983) , and analysed by Western blotting. Monoclonal antibodies DO-1 and WAFI-Ab3 (Oncogene Research Products) were used to detect p53 and p21, respectively. A polyclonal antibody raised against the C-terminus of cdc2 (Promega) was used to detect this protein. Phospho-speci®c polyclonal antibodies against P-Ser15 of p53 and P-Tyr15 of cdc2 (New England Biolabs) were used to detect the phosphorylated forms of these proteins. Quantitation of the p53 and p21 immunoreactive bands was carried out by densitometric traces in a Molecular Dynamics Densitometer.
Immunoprecipitation of p53
Cell lysates were prepared with 50 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM DTT, 1 mM EDTA, in the presence of inhibitors of proteases and phosphatases. p53 was immunoprecipitated with pre-made p53-agarose (OP43A, Oncogene), and fractionated by 10% SDS ± PAGE.
Treatment with a-lipoic acid a-lipoic acid (Sigma) was prepared as a stock solution of 200 mM in ethanol, and added to the cultures at various concentrations prior to preparation of nuclear cell extracts for immunoblotting.
